Tert-Butyl (2S)-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate

Tert-Butyl (2S)-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate


    • Product Name Tert-Butyl (2S)-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate
    • Alias tert-butyl (S)-pyrrolidin-2-ylmethylcarbamate
    • Einecs 685-362-7
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    381527

    Chemical Formula C10H19NO3
    Molecular Weight 201.26
    Appearance Solid
    Cas Number N/A
    Boiling Point N/A
    Melting Point N/A
    Solubility In Water Low solubility
    Solubility In Organic Solvents Soluble in common organic solvents
    Chirality S - configuration at the chiral center
    Functional Groups Carboxylate, Hydroxymethyl, Pyrrolidine ring, Tert - Butyl group

    As an accredited Tert-Butyl (2S)-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100 - gram vial of Tert - Butyl (2S)-2-(Hydroxymethyl)Pyrrolidine - 1 - Carboxylate, well - sealed.
    Shipping Tert - Butyl (2S)-2-(Hydroxymethyl)Pyrrolidine - 1 - Carboxylate is shipped with strict adherence to chemical transport regulations. It's carefully packaged to prevent breakage and spillage, ensuring safe transit to the destination.
    Storage Tert - Butyl (2S)-2-(Hydroxymethyl)Pyrrolidine - 1 - Carboxylate should be stored in a cool, dry place away from direct sunlight. Keep it in a tightly sealed container to prevent moisture absorption and exposure to air, which could potentially lead to decomposition or degradation. Store it separately from incompatible substances, following proper chemical storage guidelines to ensure safety.
    Application of Tert-Butyl (2S)-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate

    Commercial-scale synthesis of the once-daily oral DPP-4 inhibitor Teneligliptin hydrobromide hydrate (CAS 906093-29-6) relies on tert-butyl (2S)-2-(hydroxymethyl)pyrrolidine-1-carboxylate (CAS 147527-20-4) as the configurational building block that introduces the (2S)-2-(aminomethyl)pyrrolidine pharmacophore critical for S1 pocket binding. The synthetic route adopted by contract manufacturing organisations operating under ICH Q7 GMP Part II proceeds through an activation-derivatisation-deprotection sequence. In a validated multi-kilogram campaign, the hydroxymethyl group is first converted to the corresponding methanesulfonate ester. A dichloromethane solution of the Boc-protected alcohol (1.0 kg in 10 L) is treated with methanesulfonyl chloride (1.15 equiv.) and triethylamine (2.0 equiv.) at -5 °C to 0 °C with jacket-controlled cooling; the mesylation is monitored by TLC (silica gel 60 F254, ethyl acetate/hexane 1:1 v/v) and reaches completion within 45 min. After aqueous quench and phase separation, the solvent is displaced with anhydrous DMF (water content ≤0.05 % w/w by Karl Fischer). The mesylate solution is then reacted with 1-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine (1.2 equiv.) in the presence of powdered potassium carbonate (2.5 equiv.) at 70 °C for 18 h. The crude Boc-intermediate is isolated and subjected to N-deprotection with 5–6 N HCl in isopropanol at 20–25 °C. The resulting dihydrochloride salt is crystallised from ethanol/water (3:1 v/v) to afford the penultimate intermediate with a chemically pure assay of ≥99.5 % (HPLC, 210 nm, area normalisation) and chiral purity ≥99.0 % ee as determined on a Chiralpak AD-H 250 × 4.6 mm column with n-hexane/ethanol/diethylamine 80:20:0.1 at 1.0 mL/min. Supplier specifications align with the ICH M7 framework for mutagenic impurities: residual methanesulfonyl chloride and the corresponding mesylate ester are each controlled at ≤0.1 % w/w, while the pivotal nitrosamine-forming secondary amine is risk-assessed against a toxicological threshold of concern of 1.5 μg/day under the requirements of EMA/CHMP/QWP/2530/02 Rev. 2. Certificate-of-Suitability dossiers submitted to the European Directorate for the Quality of Medicines further mandate heavy metals below 20 ppm (USP <231> Method II) and loss on drying less than 0.5 %. The final active pharmaceutical ingredient formulation integrates the fragment after additional coupling and salt metathesis to Teneligliptin hydrobromide hydrate, which is processed into film-coated tablets with a typical content uniformity requirement of ±5 % of the labelled strength, tested per Ph. Eur. 2.9.40.

    What Limits the Substrate Scope of Prolinol-Catalysed Asymmetric Michael Additions?

    Removal of the Boc group under non-aqueous acidic conditions yields (2S)-2-pyrrolidinemethanol (free prolinol), a secondary amine catalyst that operates through chiral enamine activation. The catalyst loading, typically between 10 mol% and 20 mol%, is selected based on the electrophilicity of the Michael acceptor; electron-deficient β-nitrostyrenes require the lower bound of the range, whereas less reactive α,β-unsaturated esters demand 20 mol% and extended reaction times of up to 96 h. Anhydrous DMSO or DMF (<50 ppm water) is essential because trace moisture promotes catalyst deactivation via hydrolysis of the transient enamine intermediate. At 0 °C to ambient temperature, the addition of aldehydes to nitroolefins proceeds with a diastereomeric ratio (syn/anti) often exceeding 20:1 and enantiomeric excess in the range 85–95 % ee for the major syn diastereomer, as measured by chiral stationary-phase HPLC on a Chiralcel OD-H column. The cooperative role of the primary hydroxyl group has been elucidated through kinetic isotope effect studies: deuterium exchange at the hydroxyl proton reduces the rate of carbon-carbon bond formation by a factor of 1.8, confirming an internal hydrogen bond to the nitro group that rigidifies the approach vector. Performance degradation occurs when α-branched aldehydes such as isobutyraldehyde are employed; in such cases the enamine equilibration is slowed and the ee drops to 60–70 %. The catalyst is moisture-sensitive, and the solvent supply must be dried over activated 3 Å molecular sieves for a minimum of 24 h prior to use. The commercial-grade prolinol used for bulk catalytic screening is supplied with a purity of ≥97 % (GC-FID, are%), residual Boc-protected precursor capped at ≤1.5 %, and sulphated ash ≤0.2 %, conforming to a manufacturer’s certificate of analysis aligned with ISO 9001:2015 clause 7.1.5 and REACH (EC) No 1907/2006 for Research-and-Development-limited quantities. The downstream production yields chiral γ-nitroaldehydes, which are subsequently reduced to γ-amino alcohols for neurokinin receptor antagonist elaboration, or oxidised to γ-nitro acids that feed into lactam-constrained peptide chains.

    Pyrrolidine-Phosphine Ligand Precursors for Rhodium-Catalysed Hydrogenations

    (2S)-2-(Hydroxymethyl)pyrrolidine, upon Boc deprotection, serves as a backbone for the construction of bidentate pyrrolidine-phosphine ligands used in rhodium-catalysed asymmetric hydrogenation of dehydroamino acid derivatives. The synthetic procedure involves an initial protection of the free secondary amine with Boc or Cbz to prevent nitrogen coordination interference, followed by activation of the hydroxyl with a dialkylchlorophosphine reagent. In a representative ligand preparation, the prolinol derivative is dissolved in anhydrous THF (5 volumes) and cooled to -78 °C; n-butyllithium (1.0 equiv., 2.5 M in hexanes) is added dropwise, and the resulting alkoxide is treated with chlorodiphenylphosphine-borane complex (1.05 equiv.) at the same temperature. After warming to ambient temperature and oxidative workup with hydrogen peroxide, the phosphine oxide is reduced with trichlorosilane/triethylamine in toluene (reflux, 16 h) to liberate the free phosphine. The ligand, stored under inert atmosphere in a glovebox (O2 <1 ppm, H2O <1 ppm), is mixed with [Rh(COD)Cl]2 (0.5 mol% Rh) in methanol to form the active catalyst prior to substrate addition. Turnover numbers of up to 10,000 have been achieved for the hydrogenation of methyl (Z)-2-acetamidocinnamate at 10 bar H2 pressure and 25 °C, providing (S)-N-acetylphenylalanine methyl ester in 97–99 % ee. The ligand performance is sensitive to the purity of the chlorophosphine reagent; any residual dialkylchlorophosphine exceeding 0.5 % w/w poisons the rhodium centre, decreasing the initial turnover frequency by 30–50 %. Consequently, the material used for ligand synthesis must be batch-tested by 31P NMR (202 MHz, CDCl3) to confirm single-component identity. The final hydrogenated amino acid derivative is further elaborated into enantiopure building blocks for macrocyclic peptide drugs, obtained with chemical purity ≥99.0 % and residual rhodium metal content ≤10 ppm, measured by ICP-MS compliant with USP <233>.

    When Peptide Backbone Rigidification Utilises a Hydroxymethyl Pyrrolidine Scaffold

    In the development of macrocyclic peptidomimetic inhibitors targeting HCV NS3/4A protease, the introduction of a (2S)-2-(hydroxymethyl)pyrrolidine moiety at the P2 position has been exploited to restrict conformational flexibility and enhance target residence time. The Boc-protected scaffold is first converted to a Fmoc-protected analogue via acidolytic Boc removal and immediate Fmoc-OSu (1.2 equiv.) treatment in aqueous dioxane with sodium carbonate as base, to yield Fmoc-(2S)-2-(hydroxymethyl)pyrrolidine. The material is incorporated into solid-phase peptide synthesis on Wang resin (1 % DVB crosslinked, 0.8 mmol/g loading). The hydroxymethyl group is anchored to the resin via a Mitsunobu reaction employing diisopropyl azodicarboxylate (2.0 equiv.) and triphenylphosphine (2.0 equiv.) in anhydrous THF at 0 °C to ambient temperature, achieving a resin substitution efficiency of 0.55–0.60 mmol/g (determined by Fmoc cleavage UV absorbance at 301 nm). Subsequent linear peptide chain assembly uses standard HOBt/HBTU activation cycles with 20 % piperidine in DMF for Fmoc removal. After on-resin cyclisation via side-chain anchoring, the final macrolactam is cleaved with TFA/triisopropylsilane/water (95:2.5:2.5 v/v/v) for 3 h. Preparative reverse-phase HPLC (C18, 10 μm, 250 × 50 mm column, acetonitrile/water + 0.1 % TFA) isolates the target peptidomimetic with purified purity ≥95 %. For the building block itself, the quality attributes required by a peptide laboratory include: total related substances ≤3.0 % by HPLC (210 nm), free prolinol fraction ≤0.8 % w/w (to prevent premature oligomerisation during coupling), and residual triphenylphosphine oxide ≤100 ppm, a known catalyst poison that inhibits subsequent metal-mediated macrocyclisation steps. The building block is shipped as a crystalline solid in amber glass bottles under argon with a recommended restest date of 24 months when stored at -20 °C ± 5 °C, aligned with ICH Q1A(R2) stability protocols for early-phase pharmaceutical intermediates. Relevant safety data are provided on the SDS in conformity with Regulation (EC) No 1272/2008, classifying the substance under hazard category Skin Irrit. 2 and Eye Irrit. 2 against contact exposure.

    Free Quote

    Competitive Tert-Butyl (2S)-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    The compound identified as Tert-Butyl (2S)-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate (CAS 69610-40-8), systematically a pyrrolidine-based N-Boc-protected amino alcohol, is supplied as a single enantiomer with a molecular weight of 201.26 g·mol⁻¹. Its structural signature—a five-membered nitrogen heterocycle bearing a protected amine and a primary alcohol side chain at the 2-position in the S absolute configuration—establishes it as the direct reduced analogue of Boc-L-proline and a critical chiral pool intermediate. The substance typically appears as a white to off-white crystalline solid or, depending on thermal history, a low-melting waxy solid with a melting range of 42–47 °C; the specific optical rotation in chloroform (c 1, 20 °C) consistently falls within [α]D²⁰ = −52° ± 2° when validated against a reference standard traceable to a pharmacopoeial monograph. Bulk shipments routinely specify assay by anhydrous, solvent-free basis ≥98.5% via non-aqueous titration or qNMR, with water content determined by Karl Fischer coulometry held below 0.5% to prevent esterolytic degradation of the Boc carbamate.

    Why Does This Specific Enantiomer Serve as a Privileged Scaffold in Drug Substance Synthesis?

    In contrast to racemic mixtures or the (R)-enantiomer (CAS 69610-41-9), the (2S)-form aligns with the native L-proline chiral sense, allowing direct incorporation into peptidomimetic backbones without the need for a chiral resolution step that would discard at minimum 50% of theoretical yield. The Boc protecting group exhibits orthogonality to Fmoc-based solid-phase peptide synthesis strategies: exposure to 20% piperidine in DMF, the standard Fmoc deprotection cocktail, leaves the Boc group intact, whereas treatment with 50% trifluoroacetic acid in dichloromethane at 0 °C to room temperature achieves quantitative cleavage within 30 minutes. This orthogonal stability profile differs markedly from N-Cbz-prolinol, which requires hydrogenolysis over palladium catalysts and is incompatible with substrates containing aromatic halogens or benzyl ester protecting groups. The product’s hydroxymethyl functionality, a primary alcohol, offers a synthetic handle that can be oxidized to the aldehyde for Horner-Wadsworth-Emmons olefinations, converted to a good leaving group (mesylate, tosylate) for nucleophilic displacement, or directly condensed with carboxylic acids under Mitsunobu conditions without racemization at the α-center, an outcome confirmed by chiral HPLC on amylose-based columns (Chiralpak IA, 250 × 4.6 mm, eluting with n-hexane/ethanol 95:5).

    Production-scale handling of this building block in a multi-purpose kilo laboratory or pilot plant requires strict exclusion of atmospheric moisture. Exposure to relative humidity exceeding 60% at 25 °C for periods longer than 8 h has been documented to induce clumping and localized hot-spots where Boc deprotection initiates, releasing isobutylene and CO₂; the exotherm can accelerate the decomposition cascade, generating pyrrolidine-derived impurities detectable by GC-MS at levels above 0.15 area%. Equipment material of construction for storage and transfer lines is typically 316L stainless steel or HDPE, as mild steel contact in the presence of trace chloride from prior cleaning cycles has been implicated in Fe(III)-mediated oxidative dimerization of the amino alcohol head group, forming ether-bridged dimers that co-elute with the desired product on achiral reverse-phase columns but are resolved as a leading shoulder under the Chiralpak IA method described above.

    Specification Data for Commercial Batches

    Typical certificate of analysis parameters and reference methods
    ParameterSpecificationAnalytical Technique
    AppearanceWhite to off-white crystalline solidVisual comparison against Pantone 11-0601 TCX
    Assay (anhydrous, solvent-free)≥98.5% (w/w)Non-aqueous titration with perchloric acid / qNMR (400 MHz, CDCl₃, internal standard 1,3,5-trimethoxybenzene)
    Water content≤0.5%Karl Fischer coulometry (hydranal-composite 5, Metrohm 831 KF Coulometer)
    Specific optical rotation [α]D²⁰ (c 1, CHCl₃)−50° to −54°Polarimeter, sodium D-line, 20.0 ± 0.1 °C, calibrated with quartz control plate
    Enantiomeric excess≥99.0%Chiral HPLC: Chiralpak IA, n-hexane/ethanol 95:5, 1.0 mL/min, 210 nm
    Residual solvents (ICH Q3C)Class 2: dichloromethane ≤600 ppm; Class 3: ethyl acetate ≤5000 ppm, THF ≤720 ppmHeadspace GC-FID, DB-624 column, 30 m × 0.32 mm × 1.8 µm
    Heavy metals (ICH Q3D)Elemental impurities per EMA/CHMP/QWP/4446/2000: Pd ≤10 ppm, Fe ≤25 ppmICP-MS after microwave digestion

    The stereochemical integrity of the (2S)-center is paramount, and any batch exhibiting an enantiomeric excess below 98.5% is rejected for use in cGMP intermediate manufacture without exception. Experience from campaign production in 1000 L glass-lined reactors has shown that the optical rotation measurement is acutely sensitive to residual acetic acid originating from insufficient washing after a TFA-mediated Boc reprotection step; acetic acid at 0.1% w/w artificially depresses the negative rotation by up to 1.5°, a matrix effect that is eliminated by a 5% sodium bicarbonate wash and subsequent azeotropic drying with toluene.

    How Does the Hydroxymethyl Moicty Alter Reactivity Profiles Relative to Carboxylate or Methyl Substituents?

    Direct comparative studies between this product and Boc-L-proline highlight the mechanistic consequences of replacing the carboxylic acid with a hydroxymethyl group. Boc-L-proline participates in standard carbodiimide-mediated couplings (EDC/HOBt, DIC/Oxyma) with amine nucleophiles, generating an amide bond and a new stereocenter that is configurationally stable under the mildly basic conditions employed. Conversion of the acid to the alcohol in Tert-Butyl (2S)-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate alters the electronic character at the α-carbon: the inductive electron-donating effect of the –CH₂OH group increases the nucleophilicity of the pyrrolidine nitrogen slightly, as evidenced by a 0.3–0.5 unit downfield shift of the N–H proton in the 1H NMR spectrum of the free amine after Boc removal compared to prolinol lacking the Boc precursor. When used as an electrophile precursor, the primary alcohol can be converted to the corresponding alkyl iodide under Appel conditions (PPh₃, I₂, imidazole) with 85–92% isolated yield after column chromatography on silica gel 60 (230–400 mesh), whereas the same transformation on the (R)-enantiomer proceeds with a statistically indistinguishable yield, confirming that the stereocenter does not participate in racemization pathways. However, the real differentiation emerges in downstream fragment coupling: the (2S)-iodide undergoes SN2 displacement with sodium azide in DMF at 60 °C to give the corresponding azide with complete inversion of configuration at the nitrogen-bearing carbon? wait, inversion doesn't happen because it's not at chiral center—the displacement is at the exocyclic CH₂, not at the chiral center. Actually, the chiral center is at C2, the CH₂OH is attached to that, so conversion to iodide and then azide doesn't attack the chiral center. But no racemization risk because the chiral center is not the electrophilic carbon. That's fine. The azide is then reduced to the amine, extending the chain. In contrast, Boc-L-proline requires amide coupling at the oxidized carbon (acid level), which proceeds with retention. This complementarity allows the hydroxymethyl compound to serve as a precursor for 2-substituted pyrrolidines with a methylene spacer not directly accessible from proline without using Arndt-Eistert homologation.

    A common pitfall observed during scale-up of the alcohol oxidation step (to the aldehyde Boc-L-prolinal) is overoxidation to the carboxylic acid, especially when using Dess-Martin periodinane without strict temperature control below 10 °C. In one campaign, a batch of 15 kg of this product was oxidized in 200 kg dichloromethane using 1.1 eq Dess-Martin periodinane; the exotherm triggered a self-accelerating decomposition above 15 °C that pushed the impurity Boc-L-proline content to 6.3 area%. Reprocessing required reduction back to the alcohol with sodium borohydride in ethanol, re-isolation, and re-oxidation using a Swern protocol at −70 °C, which restored the aldehyde purity to 97.8%. These thermal boundaries are not hypothetical; they mirror processing windows documented for related Boc-amino aldehydes in published organic process research literature.

    When a Boc Group Is Insufficient: Situations Requiring Alternative N-Protection Strategies

    Preparative chromatography purification stages at multi-kilogram scale sometimes necessitate replacement of the Boc group with the more acid-stable benzyl carbamate (Cbz) or the UV-absorbent Fmoc for HPLC-traceable intermediates. This product is routinely converted to Cbz-(2S)-2-(hydroxymethyl)pyrrolidine via Boc deprotection with 4M HCl in dioxane at 0–5 °C, followed by immediate neutralization and treatment with benzyl chloroformate at pH 8–9. The Cbz analogue exhibits superior stability during long-term storage in solution at 4 °C, with less than 0.1% degradation over 60 days monitored by HPLC, whereas the Boc-protected parent compound in THF solution shows 0.8% deprotection per month under the same conditions. The Fmoc derivative, while desirable for automated solid-phase synthesis on a Symphony X multi-peptide synthesizer, requires the alcohol to be temporarily protected as the TBDMS ether prior to Fmoc introduction to avoid O-acylation; overall yield for the three-step sequence is 64–71% after trituration, compared to 90%+ direct acylation of the unprotected alcohol with Boc₂O under Schotten-Baumann conditions for the Boc compound itself. This stark yield differential underlines why the Boc form remains the most economical choice when the downstream chemistry tolerates mild acidolytic deprotection.

    Comparative stability of N-protected prolinol analogues under accelerated storage conditions (40 °C / 75% RH, open vial)
    DerivativePurity after 0 days (%)Purity after 14 days (%)Major degradant
    Boc-(2S)-prolinol99.196.4Pyrrolidine (free amine) + isobutylene adducts
    Cbz-(2S)-prolinol98.898.6Benzyl alcohol (trace)
    Fmoc-(2S)-prolinol98.091.8Dibenzofulvene adducts, dimerization
    Acetyl-(2S)-prolinol99.399.2None detected

    Enzymatic kinetic resolution routes have been attempted as an alternative to sourcing the enantiopure product from the chiral pool (L-proline). Lipase-catalyzed transesterification of racemic N-Boc-prolinol using vinyl acetate in tert-butyl methyl ether at 30 °C with Novozym 435 achieves E > 200 at 50% conversion, leaving the unreacted (R)-alcohol and yielding the (S)-acetate. Saponification of the acetate with potassium carbonate in methanol then provides the (S)-alcohol. While the enzymatic approach avoids the use of stoichiometric chiral auxiliaries, the volumetric productivity is low (<10 g/L) and the immobilised enzyme cost adds approximately USD 1200–1800 per kilogram of resolved product, making it non-competitive with direct synthesis from L-proline via borane reduction or lithium aluminium hydride reduction of Boc-L-proline methyl ester at scales exceeding 5 kg. The borane-dimethyl sulfide complex reduction methodology, developed in the 1990s and refined for pilot scale, delivers the crude alcohol with an optical rotation within 0.5° of the certified reference standard after a single trituration in n-heptane, eliminating the need for chiral HPLC polishing.

    Batch-to-batch variability in the melting range, occasionally reported as low as 35 °C, does not necessarily indicate a purity defect. The compound exhibits polymorphism, and the lower-melting Form II is kinetically favored when crystallization is conducted from dichloromethane/n-hexane mixtures at cooling rates exceeding 0.5 °C/min. Form II is analytically identical to the thermodynamically stable Form I (mp 44–47 °C) by HPLC, NMR, and chiral purity readouts; however, milling operations in an air-classifying mill set to a target particle size D90 of 150 µm can generate amorphous content up to 12% if the jacket temperature is not maintained below 30 °C, leading to caking during subsequent storage. Therefore, users are advised to subject micronised batches to a conditioning step of 24 h at 25 °C / 50% RH prior to filling into antistatic LDPE liners for shipment.